Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2026-02-06 @ 12:16 AM
Study NCT ID:
NCT00474006
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2007-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
Sponsor:
Cooperative Study Group A for Hematology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ACUTE MYELOGENOUS LEUKEMIA | View |
Keywords: